✦ LIBER ✦

Pretherapeutic identification of high-risk acute myeloid leukemia (AML) patients from immunophenotypic, cytogenetic, and clinical parameters

✍ Scribed by Valet, G. ;Repp, R. ;Link, H. ;Ehninger, A. ;Gramatzki M, M. ;,

Publisher: John Wiley and Sons
Year: 2003
Tongue: English
Weight: 80 KB
Volume: 53B
Category: Article
ISSN: 0196-4763
DOI: 10.1002/cyto.b.10028

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improved outcome of patients with low- a

Improved outcome of patients with low- and intermediate-risk cytogenetics acute myeloid leukemia (AML) in first relapse with gemtuzumab and cytarabine versus cytarabine : Results of a retrospective comparative study

✍ Thomas Prebet; Anne Etienne; Raynier Devillier; Emilie Romeo; Aude Charbonnier; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 202 KB 👁 1 views

Results of a multicenter phase II trial

Results of a multicenter phase II trial for older patients with c-Kit-positive acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR-MDS) using low-dose Ara-C and Imatinib

✍ Florian Heidel; Jorge Cortes; Frank G. Rücker; Walter Aulitzky; Laurie Letvak; T 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views